Advertisement

Topics

Alexion Reaches Funding Agreement with NICE and NHS England for Strensiq® (asfotase alfa) for ...

23:06 EDT 4 Jul 2017 | BioMedReports - Blog

Alexion:
Media
Kim Diamond, +1 475-230-3775
Executive Director, Corporate Communications
or
Lauren Cettier, +41 (0)44 457 4323
Director, External Communications, EMEA
or
Investors
Elena Ridloff, CFA, +1 475-230-3601
Vice President, Investor Relations
or
Catherine Hu, +1 475-230-3599
Director, Investor Relations

Read more...

Original Article: Alexion Reaches Funding Agreement with NICE and NHS England for Strensiq® (asfotase alfa) for ...

NEXT ARTICLE

More From BioPortfolio on "Alexion Reaches Funding Agreement with NICE and NHS England for Strensiq® (asfotase alfa) for ..."

Advertisement
Quick Search
Advertisement
Advertisement